Bimatoprost Solution/ Drops
Product Images NDC 42571-128

10 FDA label images from Micro Labs Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bimatoprost (NDC 42571-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bimatoprost Crtn A

Bimatoprost Crtn A
Packaging label for Bimatoprost Ophthalmic Solution 0.03%, a sterile eye drop solution with a volume of 2.5 mL. The label includes dosage strength (0.03%), usage indication for eyes only, and manufacturer Micro Labs Limited, based in Bangalore, India. The label also features storage instructions and includes barcodes and regulatory information.*
FDA Label Image

Bimatoprost Crtn B

Bimatoprost Crtn B
Bimatoprost Ophthalmic Solution 0.03% label for a 5 mL sterile solution. The packaging indicates use for eyes only, prescription use only, and includes active ingredient bimatoprost 0.3 mg/mL. Manufactured by Micro Labs Limited, the label provides storage instructions (2° to 25°C) and notes that the bottle is filled to half capacity. The design includes barcodes and Micro Labs branding.*
FDA Label Image

Bimatoprost Crtn C

Bimatoprost Crtn C
The packaging label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) features information for a 7.5 mL sterile solution for ocular use. It is labeled for prescription use only and produced by Micro Labs Limited, with manufacturing details and barcode included. The label also lists active and inactive ingredients, storage instructions, and dosage directions for eye application.*
FDA Label Image

Bimatoprost Inst A

Bimatoprost Inst A
Illustration showing a bottle with a dropper cap and a tear off tamper evident ring. The parts labeled include the cap, bottle, and tear off tamper evident ring on the neck of the bottle.*
FDA Label Image

Bimatoprost Inst B

Bimatoprost Inst B
An instructional illustration showing a hand twisting off the cap of an ophthalmic solution dropper bottle labeled BIMATOPROST 0.3 mg/mL by Micro Labs Limited.*
FDA Label Image

Bimatoprost Inst C

Bimatoprost Inst C
Instructional diagram showing a hand holding a small ophthalmic bottle of Bimatoprost solution/drops and turning the cap to open or close it.*
FDA Label Image

Bimatoprost Labl A

Bimatoprost Labl A
Label for Bimatoprost Ophthalmic Solution 0.03% in a 2.5 mL bottle. The label includes the NDC 42571-128-35 and indicates the product is for eye use only. Manufactured by Micro Labs Limited, India, and manufactured for Micro Labs USA, Inc., Somerset, NJ. The label also features a barcode and Pharma Code.*
FDA Label Image

Bimatoprost Labl B

Bimatoprost Labl B
Label for Bimatoprost Ophthalmic Solution 0.03%, a 5 mL eye drop solution. It is manufactured by Micro Labs Limited, India, and labeled for Micro Labs USA, Inc., Somerset, NJ. The label includes the NDC number 42571-128 and indicates the product is for prescription use only.*
FDA Label Image

Bimatoprost Labl C

Bimatoprost Labl C
Label for Bimatoprost Ophthalmic Solution 0.03%, a 7.5 mL solution for ocular use. The product is manufactured by Micro Labs Limited in India for Micro Labs USA, Inc. The label includes the NDC number 42571-128-28 and states 'For Use in the Eyes Only.'*
FDA Label Image

Bimatoprost Stru

Bimatoprost Stru
Chemical structure diagram of the active ingredient bimatoprost, showing its molecular configuration as used in the ophthalmic solution product by Micro Labs Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.